What are suitable alternatives to Gabapentin (Neurontin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pregabalin is a suitable alternative to gabapentin, as they belong to the same class of medications (gabapentinoids) and work through similar mechanisms, with pregabalin often prescribed at doses ranging from 75-300 mg twice daily, with a maximum daily dose of 600 mg 1. When considering alternatives to gabapentin, it's essential to evaluate the underlying condition being treated, such as neuropathic pain, seizures, or anxiety.

  • Pregabalin has shown efficacy in treating neuropathic pain, with a more straightforward dosing regimen compared to gabapentin due to its linear pharmacokinetics 1.
  • Other potential alternatives include tricyclic antidepressants like amitriptyline (10-75 mg daily) or duloxetine (30-60 mg daily), which have been studied in the treatment of neuropathic pain 1.
  • The choice of alternative medication should be based on the individual patient's needs and medical history, taking into account potential side effects and interactions.
  • It's crucial to switch medications gradually under medical supervision to avoid withdrawal symptoms and monitor for any changes in side effects, such as dizziness, drowsiness, or dry mouth 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Alternatives to Gabapentin

  • Pregabalin: a GABA analogue closely related to gabapentin, approved for use in refractory partial epilepsy and neuropathic pain 2, 3
  • Duloxetine: a medication approved by the US Food and Drug Administration (FDA) for the treatment of neuropathic pain 4
  • 5% lidocaine patch: a topical medication approved by the FDA for the treatment of neuropathic pain 4
  • Carbamazepine: an antiepileptic drug approved by the FDA for the treatment of neuropathic pain, although evidence suggests it may have limited efficacy 5, 4
  • Tricyclic antidepressants: a class of medications with proven efficacy in multiple randomized, placebo-controlled trials for the treatment of neuropathic pain 5, 4
  • Venlafaxine: an antidepressant with proven efficacy in multiple randomized, placebo-controlled trials for the treatment of neuropathic pain 4
  • Tramadol: an opioid with proven efficacy in multiple randomized, placebo-controlled trials for the treatment of neuropathic pain 4
  • Opioids: a class of medications with proven efficacy in multiple randomized, placebo-controlled trials for the treatment of neuropathic pain, although their use is often limited by side effects and risk of dependence 4

Efficacy of Alternatives

  • Pregabalin: has been shown to be effective in reducing pain intensity in patients with neuropathic pain, with a number needed to treat (NNT) of 4 to 10 5
  • Gabapentin: has been shown to be effective in reducing pain intensity in patients with postherpetic neuralgia and painful diabetic neuropathy, with an NNT of 5.9 to 8.0 6
  • Duloxetine: has been shown to be effective in reducing pain intensity in patients with neuropathic pain, although the exact NNT is not specified 4
  • Tricyclic antidepressants: have been shown to be effective in reducing pain intensity in patients with neuropathic pain, although the exact NNT is not specified 5, 4

Safety and Tolerability of Alternatives

  • Pregabalin: has a similar adverse effects profile to gabapentin, including dizziness, drowsiness, and weight gain 2, 3
  • Gabapentin: has been associated with adverse effects such as dizziness, somnolence, and peripheral edema, although serious adverse events are rare 6
  • Duloxetine: has been associated with adverse effects such as nausea, headache, and dizziness, although serious adverse events are rare 4
  • Tricyclic antidepressants: have been associated with adverse effects such as dry mouth, constipation, and dizziness, although serious adverse events are rare 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pregabalin: new drug. Very similar to gabapentin.

Prescrire international, 2005

Research

Pregabalin: a new agent for the treatment of neuropathic pain.

Drugs of today (Barcelona, Spain : 1998), 2005

Research

Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

The Cochrane database of systematic reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.